Barbara Stokes’ Career In Business

Barbara Stokes is a successful businesswoman. She is employed at GSH of Alabama as the CEO. GSH of Alabama manufactures homes, and these are some of the most durable manufactured homes on the market. Prior to working for GSH of Alabama, she had a long career in business management.

What Education Does She Have?

She attended Mercer University, and she graduated with a degree in biomedical engineering and physics. However, Barbara Stokes also studied other subjects while she was there. She studied business management, thermodynamics, and the science of materials. Follow Barbara Stokes on Facebook.

Where Was She Employed Before She Worked For GSH of Alabama?

She worked for Boeing and Pisces Corporation before GSH Of Alabama hired her. While these companies are very different from GSH Of Alabama, her employment helped her to become more skilled at arranging contracts with the government.

What Types Of Homes Does GSH Of Alabama Produce?

GSH Of Alabama builds many different types of homes. While they have many different types of homes, all of them are designed to be able to resist serious natural disasters. In addition to being able to withstand hurricanes and other weather-related events, they can resist fire damage and mold damage. Homes that are built by GSH of Alabama can resist wind speeds that are as high as 130 miles an hour. They are also less susceptible to rodents than most homes.

Their homes tend to have a higher value than most other manufactured homes. Furthermore, their homes tend to include features that are not typically found in a manufactured home, such as granite countertops. Another common feature of their homes is marble countertops. Read more about Barbara Stokes at

The Accreditation Of The Company:

GSH Of Alabama has been accredited by the AIA, NFPA, and the NSPE. These accreditations provide strong evidence that Barbara Stokes’ company is a reputable organization.


Oncotarget Doubling its Publication Schedule

Oncotarget is an online medical journal that focuses on oncology but also publishes research and articles about other fields. The bio-medical journal is peer-reviewed and open-access. It has been in publication for several years, making its first publication back in 2010. Up to date, Oncotrget has published 324 issues and is currently working at it 8th volume.

Oncotarget recently expanded upon their efforts and started publishing twice a week. The Oncotargt journal is available on several vast archives such as the PubMed, ISI Web of Science, Biological Abstracts, and many others as well. The online biomedical journal of Oncotrget has been working with the National Library of Medicine. Learn more about Oncotarget at Research Gate.

The Oncotarget journal has been working towards extending its scope of topics. The primary one is oncology, but the biomedical journal provides studies and research in fields such as Immunology, Aging, Microbiology, Pathology, Autophagy, Chromosomes, and several other topics as well. Oncotarget decided to double its publication schedule in order to provide more information for practitioners, experts, and the general public. The biomedical journal is working with a number of prominent indexes and archives to offer the research and data to it readers.

Oncotarget is edited by two editors in chief from the Roswell Park Cancer Institute. Dr. Mikhail Blagosklonny has been working in cancer research for decades, and so has Dr. Andrei V. Gudkov. They also specialize in ging and cardiology.


Dr. Mikhail Blagosklonny received his higher education in Rusia where he was born. His alma mater is the First Pavlov State Medical University in the vast city of St. Petersburg. From there, Dr. Mikhail Blagosklonny achieved a degree in Cardiology. He also holds an M. D. in Internal Medicin and a Ph. D. in Experimental medicine.

From Russia, Dr. Mikhil Blagosklonny moved to the United States of America. He took up a position t the N York Medical Collge as an associate professor of medicine in 2002. After that, Dr. Mikhail Blagosklonny was apart of the Ordway Research Institute in Ne York as a senior scientist.

Dr. Mikhail Blagoklonny wished to expand upon his research and delve deeper into the field. He started working at the Rowell Park Cancer Institute in 2009. Check Oncotarget journal at

Jorge Moll’s Strive to Advance Brazil’s Health Care

Jorge Moll is a renowned businessman in Brazil. He is a cardiologist by proffession, and the owner and chairman of the Board of Directors of D’Or hospital network. This is by no doubt the largest privately owned, hospital network with 32 hospitals in Brazil.

According to Moll, in a Trends and Innovation in Health seminar held in early 2017, the hospital started as an examination institution in Rio de Janeiro before exploding to become the largest group of hospitals in the country. Having lived in the region, he had observed how the health sector in Rio de Janeiro city had deteriorated over the years, something which was affecting the population in the area. This illustrated to him the need of the city for a network of hospitals meant to serve the entire population thus established the first three institutions there. He further said that though they started with a lot financial struggles, the great will become the driving force enabling them to beat all the odds and rising above. Learn more about Jorge Moll at Google Scholar.

Moll said that with the economic crisis facing the country, there was a necessity of looking for an alternate way of bettering the health plans, which has over time been abandoned, with many people migrating to SUS. He presents the model of change, which is supposed to help every other “serious and respected” health care provider deliver an affordable health care, if only they would join hands with him.

With a brokerage incorporated in the plan, and with the collaboration of D’Or hospital network, they intended to help the operators get an understanding of the hospitals operations, rising the hospital standards and elaborating the patient’s treatment. Moll felt that most operators were still in the mystery of the patients treatment in their facilities, and neither did they offer any intensive follow-up up them, something that he believed they needed to have a knowledge of. Read more about Jorge Moll at

Jorge Moll strongly sentimented that Brazil was in dire need of entrepreneurial minded leaders, who will not only win the market but also stir up more entrepreneurs for the betterment of Brazil. It was time that Brazil stopped relying on only a few entrepreneurs, which was nothing less of a risky game.


Cell Therapy With Dr. Mark Holterman, Pediatric Expert

Dr. Mark Holterman is a man of many competencies. He is an accomplished medical researcher, surgeon, educator, CEO and philanthropist. He is the epitome of creativity and innovation in the medical fraternity.

Dr. Holterman who has 29 years of experience in the medical field majored in Biology at Yale University from 1976 and 1980 and graduated from University of Virginia’s School of Medicine with a degree in medicine and immunology in 1988. He later undertook his residency in general surgery at the University of Virginia Health Sciences and later completed a fellowship in pediatric surgery at Seattle Children’s Hospital and Medical Centre through the University of Washington. Read more at Vitals to know more about Dr. Mark Holterman.

The doctor who is based in Peoria, Illinois has been a full professor at the University Of Illinois College Of Medicine for seven years. He teaches surgery and pediatrics. Dr Holterman previously served as surgeon-in-chief at Advocate Christ Children’s Hospital between August 2008 and December 2010. Also, he practiced as an attending pediatric surgeon at Rush University Medical Center between August 2000 and July 2012.

In 2012, Dr. Holterman founded and is CEO of Mariam Global Health which is a global investment and business management firm that develops and implements revolutionary scientific techniques.

Dr. Holterman who specializes in pediatric surgery has performed extensive medical research in the fields of regenerative medicine, stem cell therapies, obesity in teenagers and revolutionary cancer treatments.

In his time, Dr. Holterman has received four awards among them the Innovative Research Award from the American Diabetes Association that focuses on funding research into diabetes cures and prevention. He also won the National Merit Scholar, NIH Medical Scientist Training Program and America’s Top Doctor

Dr. Holterman is a member of several professional bodies among them; American Academy of Pediatrics, American College of Surgeons, and American Diabetes Association among others. Read more about his interview at

He has also written several research papers that have been lauded as exceptional. He has also made presentations on cutting edge medical procedures on topics like bariatric surgery. This particular surgery is used to treat extreme obesity cases by removing a small part of the patient’s stomach in order to regulate food intake.

Despite his many professional obligations Dr. Mark Holterman supports many health charities among them; International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN). IPSAC-VN seeks to provide much needed healthcare and education to children in Vietnam.